{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:42:38Z","timestamp":1781134958959,"version":"3.54.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016238","name":"Dutch Ministry of Economic Affairs and Climate Policy","doi-asserted-by":"publisher","award":["PPP-2022-004"],"award-info":[{"award-number":["PPP-2022-004"]}],"id":[{"id":"10.13039\/501100016238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["ERC-COG 101125516"],"award-info":[{"award-number":["ERC-COG 101125516"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Kidney function can be assessed by the measured glomerular filtration rate (mGFR) and effective renal plasma flow (ERPF) using the exogenous filtration markers 125I-iothalamate and 131I-hippuran. These markers are unfavourable due to the radioactive burden for patients, personnel and the environment. We studied whether we could replace the measurement of these radiolabelled compounds (\u2018warm method\u2019) with the measurement of their non-radioactive isotopologues (\u2018cold method\u2019).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We determined mGFR and ERPF in 220 participants by both the warm (gamma counting) and cold (liquid chromatography\u2013tandem mass spectrometry) methods on the same serum, urine and infusion solution samples. Agreement between the methods was evaluated using Passing\u2013Bablok regression and Bland\u2013Altman analysis. Accuracy criteria were that \u226580% of the warm and cold mGFR measurements were within \u00b130% (P30) and \u226550% within \u00b110% (P10). Precision of mGFR was assessed by the standard deviation (SD) of the bias and the intratest coefficient of variation (CV%) of the measurement methods were determined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>mGFR measurements showed a mean difference of 1.97% and no clinically relevant bias when comparing the warm and cold methods. mGFR was accurate with a P30 of 100% and a P10 of 76%. The cold method was precise; the SD was 8.04\u00a0ml\/min and the intratest CV% was 3.01\u00a0\u00b1\u00a03.15%. The ERPF values showed a mean difference of 19.2% and a large constant and proportional bias. Radiochemical impurities, which influence the warm method, were found in the 131I-hippuran formulation, and these were the cause of the discrepancy between the two methods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The cold method provides equivalent mGFR results compared with the warm method. The ERPF determined using the cold method is unaffected by radiochemical impurities that significantly affect the warm method.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf293","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:56:26Z","timestamp":1758632186000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of radioactive and non-radioactive iothalamate and hippuran to assess kidney function"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4145-0459","authenticated-orcid":false,"given":"Abdulfataah A A","family":"Mohamed","sequence":"first","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology, , Groningen ,","place":["The Netherlands"]},{"name":"University of Groningen, University Medical Center Groningen Department of Nephrology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-0906","authenticated-orcid":false,"given":"Ron T","family":"Gansevoort","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Nephrology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico C","family":"van de Merbel","sequence":"additional","affiliation":[{"name":"ICON Bioanalytical Laboratories , Assen ,","place":["The Netherlands"]},{"name":"University of Groningen Department of Analytical Biochemistry, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-3240","authenticated-orcid":false,"given":"Marco","family":"van Londen","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Nephrology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-8733","authenticated-orcid":false,"given":"Martin H","family":"de Borst","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Nephrology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Zijlma","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Nuclear Medicine and Molecular Imaging, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenneke A T","family":"Junier","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-3730","authenticated-orcid":false,"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-9008","authenticated-orcid":false,"given":"Jasper","family":"Stevens","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology, , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"4 Suppl","key":"2025101515375630900_bib1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2025101515375630900_bib2","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025101515375630900_bib3","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1093\/ckj\/sfab042","article-title":"Assessment of kidney function: clinical indications for measured GFR","volume":"14","author":"Ebert","year":"2021","journal-title":"Clin Kidney J"},{"key":"2025101515375630900_bib4","article-title":"Guideline on the clinical investigation of medicinal products to prevent development\/slow progression of chronic renal insufficiency","author":"European Medicines Agency Committee for Medicinal Products for Human Use","year":"2016"},{"key":"2025101515375630900_bib5","article-title":"Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with decreased renal function","author":"European Medicines Agency Committee for Medicinal Products for Human Use","year":"2016"},{"key":"2025101515375630900_bib6","first-page":"39","article-title":"Measurement of the filtration rate","volume-title":"The kidney: structure and function in health and disease","author":"Smith","year":"1951"},{"key":"2025101515375630900_bib7","first-page":"690","article-title":"Comparison of simultaneous clearances of 125-I-labeled sodium lothalamate (Glofil) and of inulin","volume":"46","author":"Maher","year":"1971","journal-title":"Mayo Clin Proc"},{"key":"2025101515375630900_bib8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: a systematic review","volume":"64","author":"Soveri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2025101515375630900_bib9","doi-asserted-by":"publisher","DOI":"10.5772\/1298","article-title":"How measuring glomerular filtration rate? Comparison of reference methods","volume-title":"Basic nephrology and acute kidney injury","author":"Delanaye","year":"2012"},{"key":"2025101515375630900_bib10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.kint.2024.06.029","article-title":"Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium","volume":"106","author":"Ebert","year":"2024","journal-title":"Kidney Int"},{"key":"2025101515375630900_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MNM.0b013e328014a14a","article-title":"An improved equation for correcting slope-intercept measurements of glomerular filtration rate for the single exponential approximation","volume":"28","author":"Fleming","year":"2007","journal-title":"Nucl Med Commun"},{"key":"2025101515375630900_bib12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1053\/j.ajkd.2003.08.017","article-title":"Prediction of GFR in liver transplant candidates","volume":"42","author":"Skluzacek","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2025101515375630900_bib13","first-page":"97","article-title":"A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow","volume":"20","author":"Donker","year":"1977","journal-title":"Neth J Med"},{"key":"2025101515375630900_bib14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.V74567","article-title":"Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran","volume":"7","author":"Apperloo","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"2025101515375630900_bib15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/ndt\/gfv212","article-title":"Measured glomerular filtration rate is the goal, but how to measure it?","volume":"30","author":"Hulter","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2025101515375630900_bib16","doi-asserted-by":"crossref","first-page":"124329","DOI":"10.1016\/j.jchromb.2024.124329","article-title":"A validated LC-MS\/MS method for the simultaneous quantification of iothalamate and hippuran in serum and urine for non-radioactive kidney function assessment","volume":"1247","author":"Mohamed","year":"2024","journal-title":"J Chromatogr B"},{"key":"2025101515375630900_bib17","doi-asserted-by":"publisher","first-page":"e024502","DOI":"10.1136\/bmjopen-2018-024502","article-title":"Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients","volume":"8","author":"Eisenga","year":"2018","journal-title":"BMJ Open"},{"key":"2025101515375630900_bib18","doi-asserted-by":"crossref","first-page":"30001","DOI":"10.1088\/1674-1137\/abddae","article-title":"The NUBASE2020 evaluation of nuclear physics properties","volume":"45","author":"Kondev","year":"2021","journal-title":"Chin Physics C"},{"key":"2025101515375630900_bib19","article-title":"Simultaneous determination of glomerular filtration rate with 125I-iothalamate and effective renal plasma flow with 131I-hippuran","author":"Houwen"},{"key":"2025101515375630900_bib20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/BF01254570","article-title":"Iodine-131 hippuran for the estimation of renal plasma flow: requirements for radiochemical purity","volume":"22","author":"Kengen","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"2025101515375630900_bib21","volume-title":"Radiopharmaceuticals in nuclear medicine practice","author":"Kowalsky","year":"1987"},{"key":"2025101515375630900_bib22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0020-708X(80)90050-2","article-title":"Radioiodinated o-iodobenzoic acid as impurity in hippuran preparations","volume":"31","author":"Kaspersen","year":"1980","journal-title":"Int J Appl Radiat Isot"},{"key":"2025101515375630900_bib23","first-page":"372","article-title":"Evaluation of radioiodinated hipuran for the estimation of renal plasma flow","volume-title":"Proc Staff Meet Mayo Clin","author":"Burbank","year":"1961"},{"key":"2025101515375630900_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.semnuclmed.2010.09.003","article-title":"Molecular imaging of the kidneys","volume":"41","author":"Szabo","year":"2011","journal-title":"Semin Nucl Med"},{"key":"2025101515375630900_bib25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/BF00817291","article-title":"Simple purification and quality control of radio-iodinated hippuran for the estimation of effective renal plasma flow","volume":"22","author":"Kosterink","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"2025101515375630900_bib26","first-page":"850","article-title":"Radiochemical purity and in vitro stability of commercial hippurans","volume":"27","author":"Hammermaier","year":"1986","journal-title":"J Nucl Med"},{"key":"2025101515375630900_bib27","doi-asserted-by":"crossref","first-page":"012060","DOI":"10.1088\/1742-6596\/1436\/1\/012060","article-title":"Stability of 131 I-ortho-iodo-hippuric acid (131I-hippuran) labelled compound produced by CANST (Center of Applied Nuclear Science and Technology)-BATAN Bandung","volume":"1436","author":"Rosyidiah","year":"2020","journal-title":"J Phys Conf Ser"},{"key":"2025101515375630900_bib28","doi-asserted-by":"crossref","first-page":"012058","DOI":"10.1088\/1742-6596\/1436\/1\/012058","article-title":"Quality controls of radiolabeled compounds 131I-hippuran as PSTNT-BATAN product using electrophoresis method","volume":"1436","author":"Mulyati","year":"2020","journal-title":"J Phys Conf Ser"},{"key":"2025101515375630900_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0037-1620709","article-title":"Hochdruckflussigkeitschromatographische qualitatskontrolle einiger auf dem markt befindlicher 123J\/125J\/131J\/-orthojodhippurane","volume":"17","author":"Boegl","year":"1978","journal-title":"Nuklearmedizin"},{"key":"2025101515375630900_bib30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1515\/cclm-2015-0067","article-title":"Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine","volume":"53","author":"Sandberg","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2025101515375630900_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/cclm-2016-0091","article-title":"Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM strategic conference","volume":"55","author":"Ceriotti","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2025101515375630900_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cca.2021.10.016","article-title":"Setting analytical performance specifications using HbA1c as a model measurand","volume":"523","author":"Loh","year":"2021","journal-title":"Clin Chim Acta"},{"key":"2025101515375630900_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1681\/ASN.V451159","article-title":"Glomerular filtration rate measurements in clinical trials","volume":"4","author":"Levey","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"2025101515375630900_bib34","article-title":"Summary of product characteristics. Hippurate-131I for injection","author":"Polatom","year":"2016"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf293\/64353447\/sfaf293.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/10\/sfaf293\/64353447\/sfaf293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/10\/sfaf293\/64353447\/sfaf293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:38:07Z","timestamp":1760557087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf293\/8262269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf293","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,23]]},"article-number":"sfaf293"}}